Dr. Lal Gets Higher Target Price After Robust Q1, Yet ICICI Securities Downgrades Rating
While the company has reported strong growth for the last two quarters, sustainability of the run-rate in Q2 FY27 could indicate a trend change, adds the brokerage.
While the company has reported strong growth for the last two quarters, sustainability of the run-rate in Q2 FY27 could indicate a trend change, adds the brokerage.
